Pelican Capital
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Pelican Capital provides quality deal flow to family offices, allowing them to invest in growing and sustainable assets.
Investor Profile
Pelican Capital has made 7 investments, with 0 in the past 12 months and 71% as lead.
Stage Focus
- Private Equity (71%)
- Series A (14%)
- Series Unknown (14%)
Country Focus
- United Kingdom (57%)
- United States (29%)
- Ireland (14%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Health Diagnostics
- Life Science
- Cloud Computing
- Business Development
- Business Information Systems
- Business Intelligence
- Advertising
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
